cytarabine and HTLV-I Infections

cytarabine has been researched along with HTLV-I Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andresen, V; Fenizia, C; Franchini, G; Fujikawa, D; Galli, V; Gjertsen, BT; Omsland, M; Parks, RW; Pise-Masison, C	1

Other Studies

1 other study(ies) available for cytarabine and HTLV-I Infections

Article	Year
Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine. Scientific reports, 2018, 07-24, Volume: 8, Issue:1 Topics: Actin Cytoskeleton; Actins; Cell Communication; Cytarabine; Gene Products, tax; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immune System; Jurkat Cells; Leukemia, T-Cell; Nanotubes; T-Lymphocytes; Tubulin; Viral Proteins	2018

Article

Year

Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine.

Scientific reports, 2018, 07-24, Volume: 8, Issue:1

Topics: Actin Cytoskeleton; Actins; Cell Communication; Cytarabine; Gene Products, tax; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immune System; Jurkat Cells; Leukemia, T-Cell; Nanotubes; T-Lymphocytes; Tubulin; Viral Proteins

2018